Dr. rer. nat. Barbara Jentges
Barbara Jentges is Managing Director of Phact GmbH.
Barbara is a Senior Drug Regulatory Affairs Expert with more than 24 years of experience in the area of Drug Regulatory Affairs, in particular in the field of small molecule and biotech pharmaceutical products.
She has been lecturing at ETH (Swiss Federal Institute of Technology), Department of Chemistry and Applied Biosciences in Zurich, Switzerland, in the Master´s curriculum Medicinal and Industrial Pharmaceutical Sciences (MSc MIPS) (from 2008 to 2022), at the FHNW (University of Applied Sciences and Arts North-western Switzerland), School of Life Sciences, Muttenz/Basel, Switzerland (2011 to 2022), at the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG) in Bern (since 2017) and at the Bern University of Applied Sciences (since 2018). She worked for a long time as an assessor of the Federal Institute for Drugs and Medical Devices (BfArM: Bundesinstitut für Arzneimittel und Medizinprodukte) in Germany.
Within the Parenteral Drug Association (PDA) Barbara was a member of PDAs Regulatory Affairs and Quality Advisory Board and served as the European co-chair of PDAs Regulatory Affairs Interest Group.
As an editor and co-author she recently published the second edition of a book titled regarding Pharmaceutical Legislation of the European Union, Japan and the United States of America – An Overview (Second Edition 2016) issued by the Parenteral Drug Association, Inc., Bethesda, MD 20815, US.
Barbara studied pharmacy at the University of Frankfurt/M.,Germany, and obtained a doctorate in pharmaceutical chemistry from the University of Tübingen/Germany in 1990.
Managing Director of Phact GmbH (since 2006).
Assessor at the Federal Institute for Drugs and Medical Devices (BfArM), Germany,
according to §25.5 and §105 of the German drug law (AMG).
Project manager (drug regulatory affairs, GMP) with Concept Heidelberg, Germany.
Owner of a public pharmacy with a manufacturing license according to the German Drug Law (AMG); certified as ‘Qualified Person’ according to § 15 of German drug law (AMG).
Lecturer at the Swiss Federal Institute of Technology (ETH) in Zurich / Switzerland in the Master´s programme “MSc Pharmaceutical Sciences” (2008 – 2022).
Lecturer at the University of Applied Sciences and Arts Northwestern (FHNW), School of Life Sciences, Institute of Pharmaceutical Technology, Muttenz /Switzerland (2011 – 2022).
Member of the Curriculum Committee and lecturer of the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel AG), Bern/Switzerland (since 2017).
Lecturer at the Bern University of Applied Sciences, Bern / Switzerland (since 2018).
Barbara Jentges (ed.), Denyse Baker, Takayoshi Matsumura, Joanne S. Hawana.
Pharmaceutical Legislation of the European Union, Japan and the United States of America – An Overview.
Updated and Expanded 2nd. Edition.
Parenteral Drug Association, Inc., 2013, 2016.
Brigitte Friese, Barbara Jentges, Usfeya A. Muazzam.
Guide to Drug Regulatory Affairs.
Editio Cantor Verlag Aulendorf (Germany). 2009.
Former European Co-Chair of PDAs Interest Group ‘Regulatory Affairs’.
Former member of PDAs ‘Regulatory and Quality Advisory Board’ (RAQAB).